Provided by Tiger Fintech (Singapore) Pte. Ltd.

Pliant Therapeutics, Inc.

1.66
-0.0350-2.07%
Volume:357.73K
Turnover:591.02K
Market Cap:101.35M
PE:-0.48
High:1.70
Open:1.66
Low:1.62
Close:1.69
Loading ...

Pliant Therapeutics Announces Next Steps Following Dsmb Recommendation on Beacon-Ipf, a Phase 2B/3 Trial in Patients With Idiopathic Pulmonary Fibrosis

THOMSON REUTERS
·
13 Feb

Pliant Therapeutics Inc - Assembles Outside Expert Panel for Beacon-Ipf Trial Review

THOMSON REUTERS
·
13 Feb

Pliant Therapeutics downgraded to Neutral from Overweight at JPMorgan

TipRanks
·
11 Feb

Sector Update: Health Care Stocks Retreat Monday Afternoon

MT Newswires Live
·
11 Feb

Pliant Therapeutics Pauses Enrollment in BEACON-IPF Trial, Shares Take Steep Dive

GuruFocus.com
·
11 Feb

Pliant Therapeutics Shares Tumble Amid Analyst Downgrades Following Study Suspension

MT Newswires Live
·
11 Feb

Pliant Therapeutics Cut to Hold From Buy by Canaccord Genuity

Dow Jones
·
10 Feb

Pliant Therapeutics Shares Fall 60.2% After Co Halts Enrollment in Mid-Stage Trial for Lung Disease Treatment

THOMSON REUTERS
·
10 Feb

Pliant Therapeutics Cut to Equal-Weight From Overweight by Wells Fargo

Dow Jones
·
10 Feb

Pliant Therapeutics Inc : Wells Fargo Cuts Target Price to $4 From $41

THOMSON REUTERS
·
10 Feb

Pliant Therapeutics Inc : Wells Fargo Cuts to Equal Weight From Overweight

THOMSON REUTERS
·
10 Feb

Sector Update: Health Care Stocks Flat to Edging Higher Pre-Bell Monday

MT Newswires Live
·
10 Feb

Pliant Therapeutics Inc : JP Morgan Cuts to Neutral From Overweight

THOMSON REUTERS
·
10 Feb

Pliant Therapeutics Pauses Lead Product Mid-Stage Trial In Patients With Stiff Lung Tissues

Benzinga
·
10 Feb

Pliant Therapeutics Inc. : Oppenheimer Cuts to Perform From Outperform

THOMSON REUTERS
·
10 Feb

Top Premarket Decliners

MT Newswires Live
·
10 Feb